John Craig Thompson, President & CEO at Anthera Pharmaceuticals Inc (ANTH), bought 8,550 shares at $1.32 ($11K) on 2017-09-20, disclosed to the SEC on 2017-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TTPH | SELL | 2015-07-08 | $479K | — | Filing → |
| TTPH | SELL | 2015-06-16 | $415K | — | Filing → |
| TTPH | SELL | 2015-06-10 | $973K | — | Filing → |